Latest Articles

Publication Date
Amygdalin inhibits 17β-estradiol-induced mesenchymal transition through TGF- β/Smad signaling in normal and endometriotic endometrial epithelial cells.

Endometriosis is a common gynecological disorder characterized by chronic pelvic pain, infertility, and systemic symptoms, with currently limited treatment options. Amygdalin, a cyanogenic glycoside derived from bitter apricot kernels, has …

Published: Feb. 11, 2026, midnight
Burden and Risk Factor Patterns of Reproductive System Tumors and Non-Tumor Diseases Among Asian Women, 1990-2021: Evidence from the GBD Study.

Female reproductive system diseases, including malignant tumors such as breast, ovarian, and uterine cancers, and non-neoplastic disorders such as uterine fibroids, endometriosis, polycystic ovary syndrome (PCOS), infertility, and premenstrual syndrome …

Published: Feb. 11, 2026, midnight
Obstructed Hemivagina with Ipsilateral Renal Anomaly: Radiological Diagnosis, Outcome of Surgical Management and Literature Review.

Background and Clinical Significance: Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome is a rare Müllerian duct anomaly that is frequently misdiagnosed as primary dysmenorrhea, resulting in delayed intervention and …

Published: Feb. 11, 2026, midnight
Information Needs of Women Affected by Endometriosis and Their Environment: Qualitative Results from Participatory Workshops.

Background/Objectives: Endometriosis affects ~10% of women, causing chronic pain, reduced quality of life, and, often, infertility. As endometriosis literacy and awareness are low in society and among health care providers …

Published: Feb. 11, 2026, midnight
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India

Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade

AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade

Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE

Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer - Express Pharma

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Express Pharma

Published: Feb. 10, 2026, 6:40 a.m.
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug - CNBC TV18

AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug CNBC TV18

Published: Feb. 10, 2026, 6:11 a.m.
AstraZeneca Pharma India Gets CDSCO Nod for Cancer Drug Imfinzi - Whalesbook

AstraZeneca Pharma India Gets CDSCO Nod for Cancer Drug Imfinzi Whalesbook

Published: Feb. 10, 2026, 5:34 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!